As of the latest SEC filings, BELITE BIO, INC (BLTE) is held by 25 institutional funds. The largest fund shareholder is Eventide Healthcare & Life Sciences Fund (ETAHX), holding an estimated $52,395,810.56 in market value, representing 3.30% of its portfolio.
Funds holding BELITE BIO, INC (BLTE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BLTE
- CIK:
- 0001889109
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 3.30% | $52,395,810.56 | 328,624 | Mar 31, 2026 | May 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.30% | $33,141,517.28 | 207,862 | Mar 31, 2026 | May 28, 2026 |
|
AOFIX
ALGER SMALL CAP FOCUS FUND
|
MF | Independent / Boutique | 1.25% | $9,846,751.72 | 61,867 | Apr 30, 2026 | Jun 26, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 0.29% | $4,627,905.44 | 29,026 | Mar 31, 2026 | May 29, 2026 |
|
-
Morgan Stanley Discovery Portfolio
|
ETF | Independent / Boutique | 0.23% | $2,537,168.72 | 15,913 | Mar 31, 2026 | May 28, 2026 |
|
SPEM
State Street(R) SPDR(R) Portfolio Emerging Markets ETF
|
ETF | State Street (SPDR) | 0.01% | $1,985,984.64 | 12,456 | Mar 31, 2026 | May 28, 2026 |
|
MPEGX
Discovery Portfolio
|
MF | Morgan Stanley | 0.23% | $1,731,358.96 | 10,859 | Mar 31, 2026 | May 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.01% | $1,280,148.10 | 6,727 | Feb 28, 2026 | Apr 24, 2026 |
|
FZILX
Fidelity ZERO International Index Fund
|
MF | Fidelity | 0.01% | $795,959.16 | 5,001 | Apr 30, 2026 | Jun 26, 2026 |
|
JAFMX
Health Sciences Trust
|
MF | John Hancock | 0.34% | $765,312.00 | 4,800 | Mar 31, 2026 | May 29, 2026 |
|
ONEQ
Fidelity Nasdaq Composite Index ETF
|
ETF | Fidelity | 0.01% | $703,539.10 | 3,697 | Feb 28, 2026 | Apr 24, 2026 |
|
-
EQ/T.Rowe Price Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.33% | $526,152.00 | 3,300 | Mar 31, 2026 | May 26, 2026 |
|
GXC
State Street(R) SPDR(R) S&P(R) China ETF
|
ETF | State Street (SPDR) | 0.11% | $508,932.48 | 3,192 | Mar 31, 2026 | May 28, 2026 |
|
MMGTX
Discovery Portfolio
|
MF | Morgan Stanley | 0.23% | $394,454.56 | 2,474 | Mar 31, 2026 | May 28, 2026 |
|
MSJCX
Global Endurance Portfolio
|
MF | Morgan Stanley | 2.11% | $327,330.32 | 2,053 | Mar 31, 2026 | May 28, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.83% | $310,680.32 | 1,952 | Apr 30, 2026 | Jun 22, 2026 |
|
FITFX
Fidelity Flex International Index Fund
|
MF | Fidelity | 0.01% | $300,653.24 | 1,889 | Apr 30, 2026 | Jun 26, 2026 |
|
APIE
ActivePassive International Equity ETF
|
ETF | Independent / Boutique | 0.02% | $188,587.30 | 991 | Feb 28, 2026 | Apr 24, 2026 |
|
UGPIX
ULTRACHINA PROFUND
|
MF | Independent / Boutique | 0.68% | $152,156.96 | 956 | Apr 30, 2026 | Jun 22, 2026 |
|
AHSZX
ALGER HEALTH SCIENCES FUND
|
MF | Independent / Boutique | 0.21% | $125,099.76 | 786 | Apr 30, 2026 | Jun 26, 2026 |
|
EITEX
Parametric Tax-Managed Emerging Markets Fund
|
MF | Eaton Vance | 0.02% | $124,522.64 | 781 | Mar 31, 2026 | May 29, 2026 |
|
ALSAX
ALGER SMALL CAP GROWTH FUND
|
MF | Independent / Boutique | 0.05% | $103,294.84 | 649 | Apr 30, 2026 | Jun 26, 2026 |
|
AASOX
Alger Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.06% | $77,966.16 | 489 | Mar 31, 2026 | May 28, 2026 |
|
AISZX
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
|
MF | Independent / Boutique | 0.06% | $39,471.68 | 248 | Apr 30, 2026 | Jun 26, 2026 |
|
TNXT
T. Rowe Price Innovation Leaders ETF
|
ETF | T. Rowe Price | 0.12% | $18,654.48 | 117 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)